CBD reversed mitochondrial enlargement in Barth Syndrome cells, but not…
Cannabidiol abrogates the atypical enlargement of mitochondria in Tafazzin-deficient B-lymphoblastoid cells.
AI Summary
This cell-based study asked whether cannabidiol (CBD) could change mitochondrial shape and dynamics in Tafazzin-deficient B-lymphoblastoid cells derived from people with Barth Syndrome. Using transmission electron microscopy, the researchers found that CBD reversed the cells’ unusually enlarged mitochondria, but did not significantly change the abnormal structure of their mitochondrial cristae.
The study also found that CBD fully reversed elevated phosphorylation of Drp1 at a site that inhibits mitochondrial fission, suggesting that changes in fission may help explain the reduced enlargement. These laboratory findings support a role for CBD in regulating mitochondrial dynamics, but the abstract does not establish a benefit in people with Barth Syndrome. It also cannot show whether the findings apply beyond these cultured cells; this is an abstract-based summary, not a review of the full paper.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.